Vivo Bio Tech Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹14.20 crore, reflecting a quarter-on-quarter *(QoQ) increase of 5.11 per cent from ₹13.51 crore. This corresponds to a year-on-year *(YoY) growth of 15.54 per cent.
Operating Profit
Operating Profit stands at ₹4.45 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 18.94 per cent from ₹5.49 crore. This corresponds to a year-on-year *(YoY) decline of 11.18 per cent.
PBDT
PBDT stands at ₹3.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 29.08 per cent from ₹4.23 crore. This corresponds to a year-on-year *(YoY) decline of 14.04 per cent.
Profit Before Tax
Profit Before Tax stands at ₹0.25 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 84.08 per cent from ₹1.57 crore. This corresponds to a year-on-year *(YoY) decline of 79.84 per cent.
Net Profit
Net Profit stands at ₹-5.16 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 512.80 per cent from ₹1.25 crore. This represents a 586.79 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Vivo Bio Tech Ltd Earnings
- YOY
- QOQ
Vivo Bio Tech Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Vivo Bio Tech Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Vivo Bio Tech Ltd Financial Reports
Vivo Bio Tech Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Vivo Bio Tech | 1.69% | 0.60% | -1.09% | -10.27% | -25.86% | -34.68% |
| Biofil Chemicals | 1.41% | 3.64% | -4.72% | -1.43% | 9.01% | -26.22% |
| Vasundhara Rasy. | 0.52% | 2.88% | 11.05% | 38.10% | 16.52% | -14.35% |
| Bacil Pharma | 0.36% | -2.23% | -11.84% | -32.53% | -5.59% | 2.45% |
| Kabra Drugs | -1.23% | -4.99% | -8.17% | -19.39% | -23.89% | 7.43% |
| Shelter Pharma | 6.41% | -5.68% | -6.16% | -13.56% | -18.81% | -37.73% |
| Vivimed Labs. | -0.54% | -2.99% | -12.12% | -21.95% | -44.73% | -79.22% |
Company Info
Company Information
E D & Wholetime Director : Kalyan Ram Mangipudi
Executive Director / Whole Time Director / CFO : K Sri Kalyan
E D & Wholetime Director : Alangudi Sankaranarayanan
Independent Non Exe. Director : Shyam Sunder Tipparaju
Non Executive Director : Karopadi Shivanand Nayak
Independent Non Exe. Director : Priya Rajender Goda
Non-Exec & Non-Independent Dir : Satyanarayan Vedula
Company Secretary / Compliance Officer : Bhavish Vijayvargiya